Profile | GDS4284 / 202083_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1393.67 | 79 |
GSM687648 | Patient 402 control | 1608.11 | 81 |
GSM687653 | Patient 403 control | 999.959 | 74 |
GSM687658 | Patient 404 control | 1133.2 | 76 |
GSM687663 | Patient 411 control | 2079.92 | 84 |
GSM687668 | Patient 422 control | 1594.66 | 81 |
GSM687673 | Patient 424 control | 2106.29 | 85 |
GSM687678 | Patient 425 control | 1033.03 | 74 |
GSM687683 | Patient 427 control | 1539.65 | 80 |
GSM687688 | Patient 428 control | 1167.35 | 76 |
GSM687695 | Patient 441 control | 10488.9 | 97 |
GSM687699 | Patient 443 control | 1223.88 | 77 |
GSM687704 | Patient 444 control | 1022.37 | 74 |
GSM687707 | Patient 448 control | 899.3 | 73 |
GSM687712 | Patient 449 control | 1250.22 | 77 |
GSM687719 | Patient 450 control | 1817.11 | 83 |
GSM687724 | Patient 451 control | 1869.58 | 83 |
GSM687728 | Patient 452 control | 2005.63 | 84 |
GSM687646 | Patient 401 treated 24h | 958.766 | 73 |
GSM687649 | Patient 402 treated 24h | 1455.11 | 79 |
GSM687665 | Patient 411 treated 24h | 2152.91 | 85 |
GSM687651 | Patient 402 treated 4 weeks | 1950.88 | 83 |
GSM687667 | Patient 411 treated 4 weeks | 1373.79 | 78 |
GSM687670 | Patient 422 treated 24h | 1541.69 | 80 |
GSM687671 | Patient 422 treated 4 weeks | 1592.74 | 80 |
GSM687654 | Patient 403 treated 24h | 1029.18 | 75 |
GSM687675 | Patient 424 treated 24h | 2364.95 | 86 |
GSM687685 | Patient 427 treated 24h | 1551.97 | 80 |
GSM687656 | Patient 403 treated 4 weeks | 1248.49 | 77 |
GSM687677 | Patient 424 treated 4 weeks | 1315.52 | 78 |
GSM687687 | Patient 427 treated 4 weeks | 734.678 | 69 |
GSM687692 | Patient 428 treated 4h | 887.511 | 72 |
GSM687716 | Patient 449 treated 4h | 1119.5 | 76 |
GSM687722 | Patient 450 treated 4h | 1649.56 | 82 |
GSM687680 | Patient 425 treated 24h | 942.064 | 73 |
GSM687690 | Patient 428 treated 24h | 1102.15 | 76 |
GSM687700 | Patient 443 treated 24h | 3789.6 | 92 |
GSM687705 | Patient 444 treated 24h | 1628.73 | 81 |
GSM687714 | Patient 449 treated 24h | 1378.12 | 79 |
GSM687721 | Patient 450 treated 24h | 3529.23 | 91 |
GSM687682 | Patient 425 treated 4 weeks | 934.253 | 73 |
GSM687694 | Patient 428 treated 4 weeks | 1260.34 | 77 |
GSM687702 | Patient 443 treated 4 weeks | 1368.09 | 78 |
GSM687718 | Patient 449 treated 4 weeks | 1449.21 | 80 |
GSM687723 | Patient 450 treated 4 weeks | 1279.47 | 78 |
GSM687661 | Patient 404 treated 4h | 1183.53 | 76 |
GSM687710 | Patient 448 treated 4h | 1360.03 | 79 |
GSM687726 | Patient 451 treated 4h | 1524.59 | 80 |
GSM687730 | Patient 452 treated 4h | 5196.34 | 94 |
GSM687660 | Patient 404 treated 24h | 3286.94 | 90 |
GSM687697 | Patient 441 treated 24h | 7305.15 | 96 |
GSM687709 | Patient 448 treated 24h | 1228.91 | 77 |
GSM687725 | Patient 451 treated 24h | 2090.06 | 85 |
GSM687729 | Patient 452 treated 24h | 6544.29 | 95 |
GSM687727 | Patient 451 treated 4 weeks | 1774.37 | 82 |
GSM687731 | Patient 452 treated 4 weeks | 2670.08 | 87 |